The Yale School of Public Health welcomes four new assistant professors to its faculty ranks—Gregg Gonsalves, Yusuf Ransome, Jacob Wallace and Peng “Katie” Wang. They bring widely different scientific backgrounds and areas of expertise—HIV/AIDS, the economics of health insurance markets, the role of stigma in health disparities and using quantitative methods to measure how specific policy and programmatic decisions affect health.
They are joined by seven new associate research scientists: Amanda Brewster (HPM), Agathe Nkouawa (EMD), Nicholas “Nick” Rattray (EHS), Alysa Pomer (CDE), and in the Department of Biostatistics, Wei Wei, Ying Zhu and Hanzhu Qian.
“The 11-new faculty add to the expertise, experience and diversity of YSPH and we welcome each and every one with enthusiasm!” said Dean Sten Vermund. “They will do great work and contribute to improving public health outcomes for all in the coming decades.”
Gregg Gonsalves, Ph.D.
Assistant Professor, Department of Epidemiology of Microbial Diseases
What is your area of specialty in public health?
I am interested in measuring how specific policy and programmatic decisions affect health, whether these choices are around the treatment or prevention of a disease itself, or operating on more distal determinants of health. I use a variety of quantitative methods to do this and with the Yale Global Health Partnership (www.yaleghjp.org) seek to use these insights from research to affect policy and programmatic change.
How did you become interested in these topics?
I’ve worked on HIV, TB and HCV for close to 30 years, almost all these decades outside of academia with community groups around the world. The problems I saw happening in the field often didn’t get analyzed or addressed scientifically, which meant attempts to understand what was occurring and how to respond to events were happening in a data-free zone. Coming to get a BS and a PhD from Yale in 2008, then 2011, was driven by a need to garner a new set of skills and tools to improve people’s lives in the communities I worked in, I cared about.
What are your long-terms goals in public health?
Making an impact requires rigorous scientific work, but also means acting on the implications of your findings, which may take you into advocacy and activism. Some researchers think this is not our job, but John Snow, the father of modern epidemiology thought differently about speaking out: “I had an interview with the Board of Guardians of St. James's parish, on the evening of Thursday, 7th September, and represented the above circumstances to them. In consequence of what I said, the handle of the pump was removed on the following day.” My long-term goal is to use science and activism to save lives.
What drew you to the Yale School of Public Health?
Over the past few years, Yale has turned out to be one of the best places to work on issues of social justice and health. I couldn’t have better colleagues than I do in Amy Kapczynski (YLS) and Ali Miller(YSPH/SBS), my co-directors at the GHJP. My department chair, Albert Ko, has made an ongoing commitment to fostering this kind of work, because he knows that public health impact isn’t simply technically derived, it requires a bit of acting up.
Learn more about Gregg Gonsalves’ work at publichealth.yale.edu/people/gregg_gonsalves.profile
Yusuf Ransome, Ph.D.
Assistant Professor, Department of Social and Behavioral Sciences
What is your area of specialty in public health?
My research investigates the role of structural and psychosocial determinants (e.g., social capital, socioeconomic deprivation, and racial discrimination) that influence racial/ethnic and geography-related disparities in HIV care continuum indicators (e.g., delayed HIV diagnosis and linkage to HIV care) as well as alcohol-related health (e.g., cirrhosis and allostatic load dysregulation).
How did you become interested in these topics?
I first became interested in social determinants and HIV/AIDS outcomes from first-hand observations of how context can structure one’s behaviors. Specifically, I saw how high HIV stigma influenced social connectedness of residents in two communities where I once resided, and how that dynamic in-turn affected HIV+ individuals psychological state which dampened their agency to test for HIV earlier and after diagnosis, to seek social support (e.g., transportation assistance) for help with accessing treatment and staying retained in HIV care. My interest in racial/ethnic disparities in alcohol-related health risk stems from an unanswered paradox in social epidemiology where Blacks (compared to Whites) have lower prevalence of unhealthy alcohol use and clinical-alcohol disorders, yet experience higher prevalence rates and higher severity of adverse health that are either wholly or partially attributed to alcohol (e.g., cirrhosis, IL-6 and CRP).
What are your long-terms goals in public health?
For my HIV-related research, my long-term goals are to gain a comprehensive understanding (e.g., pathways/mechanisms and modifiers) about how social capital and other structural determinants shape the health of HIV+ individuals and communities (e.g., community viral load), and use the evidence to develop and implement interventions that can reduce or eliminate HIV disparities. In my alcohol-health research, I want to identify the epigenetic and psychosocial mechanisms that potentially explain the aforementioned paradox and then develop and test interventions to reduce or eliminate racial disparities in health.
What drew you to the Yale School of Public Health (YSPH)?
YSPH gives me a strong opportunity to develop and strengthen my research through interdisciplinary collaborations with several faculty who have overlapping research interest, across other YSPH departments, and at centers affiliated with YSPH such as the Center for Interdisciplinary Research on AIDS (CIRA). Next, the SBS Department is very supportive of social determinants of health research and that is important for me.